OrbiMed Israel GP Ltd. - Insider Trading & Ownership

Location
89 Medinat Hayehudim Street, 11 Th Floor, Herzliya, Israel
Summary
The estimated value of insider holdings of OrbiMed Israel GP Ltd. is at least $12.1M dollars as of January 5, 2023. OrbiMed Israel GP Ltd. is the 10%+ Owner of Chemomab Therapeutics Ltd. and owns shares of Chemomab Therapeutics Ltd. (CMMB) stock worth about $10.1M. OrbiMed Israel GP Ltd. is the 10%+ Owner of 9 METERS BIOPHARMA, INC. and owns shares of 9 METERS BIOPHARMA, INC. stock worth about $1.95M.
Signature
OrbiMed Israel BioFund GP Limited, /s/ Douglas Coon, Chief Compliance Officer
All Insider Reports
All Insider Reports

Notify me when OrbiMed Israel GP Ltd. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of OrbiMed Israel GP Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CMMB Chemomab Therapeutics Ltd. 10%+ Owner $10.1M Jan 3, 2023
NMTR 9 METERS BIOPHARMA, INC. 10%+ Owner $1.95M Jun 23, 2021

Insider Transactions Reported by OrbiMed Israel GP Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.